Literature DB >> 17964573

Role of NAD binding and catalytic residues in the C-terminal binding protein corepressor.

Priya Mani-Telang1, Montserrat Sutrias-Grau, Geoffrey Williams, David N Arnosti.   

Abstract

CtBP corepressor proteins potentiate the activity of many metazoan transcriptional repressors. These proteins are homologous to prokaryotic D-2-hydroxyacid dehydrogenases, possessing an NAD/NADH binding fold and conserved active site residues. When expressed in Drosophila, a catalytic site mutant retains biological activity, however, we find that an NAD binding mutant lacks biological activity. The NAD mutant, similar to a dimerization mutant, is expressed at low levels, indicating that binding of NAD/NADH may affect CtBP stability. These data support the idea that the ancestral dehydrogenase activity is not required for CtBP function, and NAD binding may play a regulatory, rather than catalytic, role.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17964573     DOI: 10.1016/j.febslet.2007.10.011

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Conserved catalytic and C-terminal regulatory domains of the C-terminal binding protein corepressor fine-tune the transcriptional response in development.

Authors:  Yang W Zhang; David N Arnosti
Journal:  Mol Cell Biol       Date:  2010-11-15       Impact factor: 4.272

2.  Crystal structures of human CtBP in complex with substrate MTOB reveal active site features useful for inhibitor design.

Authors:  Brendan J Hilbert; Steven R Grossman; Celia A Schiffer; William E Royer
Journal:  FEBS Lett       Date:  2014-03-19       Impact factor: 4.124

3.  Assembly of human C-terminal binding protein (CtBP) into tetramers.

Authors:  Andrew G Bellesis; Anne M Jecrois; Janelle A Hayes; Celia A Schiffer; William E Royer
Journal:  J Biol Chem       Date:  2018-04-26       Impact factor: 5.157

4.  Structure-guided design of a high affinity inhibitor to human CtBP.

Authors:  Brendan J Hilbert; Benjamin L Morris; Keith C Ellis; Janet L Paulsen; Celia A Schiffer; Steven R Grossman; William E Royer
Journal:  ACS Chem Biol       Date:  2015-01-30       Impact factor: 5.100

5.  Design, synthesis, and biological evaluation of substrate-competitive inhibitors of C-terminal Binding Protein (CtBP).

Authors:  Sudha Korwar; Benjamin L Morris; Hardik I Parikh; Robert A Coover; Tyler W Doughty; Ian M Love; Brendan J Hilbert; William E Royer; Glen E Kellogg; Steven R Grossman; Keith C Ellis
Journal:  Bioorg Med Chem       Date:  2016-04-20       Impact factor: 3.641

6.  Active-Site Tryptophan, the Target of Antineoplastic C-Terminal Binding Protein Inhibitors, Mediates Inhibitor Disruption of CtBP Oligomerization and Transcription Coregulatory Activities.

Authors:  M Michael Dcona; Priyadarshan K Damle; Francisco Zarate-Perez; Benjamin L Morris; Zaid Nawaz; Michael J Dennis; Xiaoyan Deng; Sudha Korwar; Sahib J Singh; Keith C Ellis; William E Royer; Dipankar Bandyopadhyay; Carlos Escalante; Steven R Grossman
Journal:  Mol Pharmacol       Date:  2019-04-29       Impact factor: 4.436

7.  C-terminal binding proteins are essential pro-survival factors that undergo caspase-dependent downregulation during neuronal apoptosis.

Authors:  Trisha R Stankiewicz; Emily K Schroeder; Natalie A Kelsey; Ron J Bouchard; Daniel A Linseman
Journal:  Mol Cell Neurosci       Date:  2013-07-13       Impact factor: 4.314

8.  The oligomeric state of CtBP determines its role as a transcriptional co-activator and co-repressor of Wingless targets.

Authors:  Chandan Bhambhani; Jinhee L Chang; David L Akey; Ken M Cadigan
Journal:  EMBO J       Date:  2011-04-05       Impact factor: 11.598

9.  Therapeutic targeting of C-terminal binding protein in human cancer.

Authors:  Michael W Straza; Seema Paliwal; Ramesh C Kovi; Barur Rajeshkumar; Peter Trenh; Daniel Parker; Giles F Whalen; Stephen Lyle; Celia A Schiffer; Steven R Grossman
Journal:  Cell Cycle       Date:  2010-09-08       Impact factor: 4.534

10.  CtBP2 Promotes Human Cancer Cell Migration by Transcriptional Activation of Tiam1.

Authors:  Seema Paliwal; Ngoc Ho; Daniel Parker; Steven R Grossman
Journal:  Genes Cancer       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.